Related references
Note: Only part of the references are listed.Correlation of PRL3 expression with colorectal cancer progression
Premila D. Leiphrakpam et al.
JOURNAL OF SURGICAL ONCOLOGY (2021)
Colorectal cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer
Premila D. Leiphrakpam et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
Prognostic Role of High Stathmin 1 Expression in Patients with Solid Tumors: Evidence from a Meta-Analysis
Qingyan Mao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma
Hai-long Ma et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Overexpression of stathmin plays a pivotal role in the metastasis of esophageal squamous cell carcinoma
Gaijing Han et al.
ONCOTARGET (2017)
Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years' discoveries and developments
Rong Biaoxue et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Molecular targets and pathways involved in liver metastasis of colorectal cancer
Ulrich H. Weidle et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer
Wei Nie et al.
LABORATORY INVESTIGATION (2015)
Ezrin expression and cell survival regulation in colorectal cancer
Premila D. Leiphrakpam et al.
CELLULAR SIGNALLING (2014)
Stathmin destabilizing microtubule dynamics promotes malignant potential in cancer cells by epithelial-mesenchymal transition
Yu Lu et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2014)
In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer
Premila D. Leiphrakpam et al.
ONCOLOGY REPORTS (2014)
Phosphatase of Regenerating Liver 3 (PRL3) Provokes a Tyrosine Phosphoproteome to Drive Prometastatic Signal Transduction
Chad D. Walls et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Stathmin 1: a protein with many tasks. New biomarker and potential target in cancer
John Nemunaitis
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Stathmin1 Plays Oncogenic Role and Is a Target of MicroRNA-223 in Gastric Cancer
Wei Kang et al.
PLOS ONE (2012)
Phosphatase PRL-3 Is a Direct Regulatory Target of TGF beta in Colon Cancer Metastasis
Yanjun Jiang et al.
CANCER RESEARCH (2011)
Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer
Jone Trovik et al.
CLINICAL CANCER RESEARCH (2011)
Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells
T-Y Jeon et al.
BRITISH JOURNAL OF CANCER (2010)
Stathmin, a New Target of PRL-3 Identified by Proteomic Methods, Plays a Key Role in Progression and Metastasis of Colorectal Cancer
Ping Zheng et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Molecular Origins of Cancer: Molecular Basis of Colorectal Cancer.
Sanford D. Markowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer
Jian Ming et al.
PATHOLOGY (2009)
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation
H. B. Salvesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
Lao H. Saal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation
Fubo Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition
Haihe Wang et al.
CANCER RESEARCH (2007)
Oncogenic PI3K and its role in cancer
Y Samuels et al.
CURRENT OPINION IN ONCOLOGY (2006)
The oncoprotein 18/stathmin family of microtubule destabilizers
L Cassimeris
CURRENT OPINION IN CELL BIOLOGY (2002)
Stathmin family proteins display specific molecular and tubulin binding properties
E Charbaut et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors
G Brattsand
BRITISH JOURNAL OF CANCER (2000)
Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours
PA Curmi et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
